Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway

References

• Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe – a review. Euro Surveill 2008;13:1–8.
   Google Scholar
• Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:41–6.
   PubMedGoogle Scholar
• Muhlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009;9:1–14.
   PubMed Web of Science ®Google Scholar
• Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556–62.
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002;36:S21–9.
   PubMed Web of Science ®Google Scholar
• Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999;341:866–70.
   PubMed Web of Science ®Google Scholar
• Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991;14:969–74.
   PubMed Web of Science ®Google Scholar
• Forns X, Ampurdanes S, Sanchez-Tapias JM, Guilera M, Sans M, Sanchez-Fueyo A, Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol 2001;35:265–71.
   PubMedGoogle Scholar
• Freeman AJ, Dore GJ, Law MG, Thorpe M, Von OJ, Lloyd AR, Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809–16.
   PubMed Web of Science ®Google Scholar
• Planas R, Balleste B, Alvarez MA, Rivera M, Montoliu S, Galeras JA, Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004;40:823–30.
   PubMed Web of Science ®Google Scholar
• Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M, The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 2006;43:1303–10.
   PubMed Web of Science ®Google Scholar
• Kristiansen MG, Gutteberg T, Berg LK, Sjursen H, Mortensen L, Florholmen J. Hepatitis C in Northern Norway. Tidsskr Nor Laegeforen 2002;122:1974–6.
   PubMedGoogle Scholar
• Iacobellis A, Ippolito A, Andriulli A. Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition. World J Gastroenterol 2008;14:6467–72.
   PubMedGoogle Scholar
• Kristiansen MG, Løchen M-L, Gutteberg TJ, Mortensen L, Eriksen BO, Florholmen J. Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in Northern Norway. J Viral Hepatol 2010, in press.
   Google Scholar
• Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology 2002;35:1247–55.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, The natural history of hepatitis C virus infection; host, viral and environmental factors. JAMA 2000;284:450–6.
   PubMed Web of Science ®Google Scholar
• Sweeting MJ, De AD, Brant LJ, Harris HE, Mann AG, Ramsay ME. The burden of hepatitis C in England. J Viral Hepatol 2007;14:570–6.
   PubMed Web of Science ®Google Scholar
• Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepatol 2009;16:650–8.
   PubMed Web of Science ®Google Scholar
• Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000;132:105–11.
   PubMed Web of Science ®Google Scholar
• Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatitis 2001;34:730–9.
   Google Scholar
• Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002;36:S47–56.
   PubMed Web of Science ®Google Scholar
• Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999;31(Suppl);17–24.
   PubMedGoogle Scholar
• Deng Li-P, Gui Xi-En, Zhang Y-Xi, Shi-Cheng G, Yang R-R. Impact of human immunodedficiency virus infection on the course of hepatitis C virus. A meta-analysis. World J Gastroenterol 2009;28:996–1003.
   Google Scholar
• Bondini S, Younossi ZM. Non-alcoholic fatty liver disease and hepatitis C infection. Minerva Gastroenterol Dietol 2006;52:135–43.
   PubMedGoogle Scholar
• Oo YH, Adams D. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 2009;1–10.
   Google Scholar
• Alter, Morbidity and Mortality Weekly Report Recomm Rep. 1998;47(RR-19):1–39.
   PubMedGoogle Scholar
• Yawn BP, Rocca LG, Wollan PC. 10-year trends in the diagnosis and treatment of hepatitis C and concomitant mental health disorders: 1995–2005. Prim Care Companion J Clin Psychiatry 2008;10:349–54.
   PubMedGoogle Scholar
• Kringlen E, Torgersen S, Cramer V. Mental illness in a rural area. A Norwegian psychiatric epidemiological study. Soc Psychiatry Psychiatr Epidemiol 2006;41:713–19.
   PubMed Web of Science ®Google Scholar
• Ayuso-Mateos JL, Vazquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard S, Casey P, Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001;179:308–16.
   PubMed Web of Science ®Google Scholar
• Sabry A, Agroudy A, Sheashaa H, El-Husseini A, Mohamed TN, Elbaz M, Sobh M. HCV associated glomerulopathy in Egyptian patients: clinicopathological analysis. Virology 2005;334:10–6.
   PubMed Web of Science ®Google Scholar
• Martinelli AL, Zago MA, Roselino AM, Filho AB, Villanova MG, Secaf M, Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection. Am J Gastroenterol 2000;95:3516–21.
   PubMedGoogle Scholar